Friday, April 24, 2020, at 9 a. m.
The Texas Drug Utilization Review Board meets quarterly to develop criteria and standards impacting Texas Medicaid, including:
- Developing and submitting recommendations for the Texas Medicaid preferred drug list
- Suggesting clinical prior authorizations on outpatient prescription drugs.
- Recommending educational interventions for Medicaid providers.
- Reviewing drug utilization across the Medicaid program.
February 27, 2020
Members Sought for the Drug Utilization Review Board
February 26, 2020
Revised Growth Hormone Clinical Prior Authorization Begins May 28
February 7, 2020
January 2020 Drug Utilization Review Board Meeting Summary
February 5, 2020
January 2020 Preferred Drug List Recommendations Now Available
February 4, 2020
Clinical Prior Authorization Assistance Chart Now Available
January 27, 2020
Jan. 2020 Preferred Drug List Published